Replies to post #8878 on BioSante Pharmaceuticals, Inc. (BPAX)

[PennyStockInvestor]

It makes perfect sense to me that BPAX would have a partnership with TEVA. Regulatory and marketing activities can be very expensive and time consuming for a smaller company like BPAX so this will work out well for them if Bio-T-Gel is FDA approved. Bio-T-Gel was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel regulatory and marketing activities. BioSante will receive certain milestone payments and royalties upon commercialization.